About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
On November 3, PhRMA sponsored The Atlantic’s People v. Cancer event, hosting “PhRMA Presents: The Future of Fighting Cancer.” PhRMA’s Chief Operating Officer, Lori Reilly, joined Eli Lilly and Company’s Jacob Van Naarden, Chief Executive Officer at Loxo@Lilly, for a conversation on recent advancements in cancer research and care, as well as the potential negative impacts of the Inflation Reduction Act on cancer research and treatment development.
When:
November 3, 2022, at 10:30 a.m. ET
Speakers:
- Lori Reilly, Esq., Chief Operating Officer, PhRMA
- Jacob Van Naarden, Executive Vice President, Eli Lilly and Company; Chief Executive Officer, Loxo@Lilly
Event
Advances in Treatment
The Future of Fighting Cancer
The Future of Fighting Cancer image